We recently developed a two-site immunofluorometric assay (IFMA) of sa
lmon calcitonin (SCT) by DELFIA (dissociation enhancement lanthanide f
luoroimmunoassay) technique using the same polyclonal antibodies both
for ''catching'' the antigen and for signaling. In the present study w
e used a monoclonal antibody to SCT 1-11 as the capture antibody. This
antibody was biotinylated before use in streptavidin-coated microtitr
ation plates. The polyclonal antibody labeled with Eu chelate was used
as a signaling marker. This combination of antibodies resulted in an
assay that was three to four times more sensitive than the previous IF
MA, with a detection limit of 0.3 pmol/L serum. Intact SCT 1-32 was de
tected by the assay (recoveries 94-96%), but not the fragments SCT 1-1
1 and SCT 10-32 or human calcitonin. Dilutions of plasma samples conta
ining SCT were parallel to the calibration curve of SCT 1-32. Pharmaco
kinetic studies of SCT, 100 IU administered intramuscularly to 10 men,
indicated peak serum concentrations of 32-128 pmol/L within 10-20 min
with apparent half-life of 56 +/- 18 min (mean +/- SD). This new assa
y will allow study of the pharmacokinetics of new calcitonin preparati
ons that do not require injection.